Sign in
Active, not recruitingNo phase

Gluten Reduction and Risk of Celiac Disease

Key facts

Who runs it
Lund University
Where
Sweden1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
1,141 people enrolled
Started
5 May 2021
Expected to end
31 Dec 2035
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Gluten reduced diet
Record updated
13 April 2026

Who can take part

Age
6 months to 6 months
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • children screened positive for HLA DQ2/X (X is neither DQ2 or DQ8)
  • children who refused enrolment to the on-going study PreSiCe (ClinicalTrials.gov Identifier NCT03562221)

Who cannot take part

  • congenital chronic disorder where intervention with diet may be affected
  • written informed consent from both caregivers are missing

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Celiac disease shares many features of other autoimmune diseases such as type 1 diabetes. Recently, it was published that higher amounts of gluten intake increased the risk for celiac disease. Optimal amounts of gluten to be introduced during weaning have not yet been established. The aim is to investigate if a gluten-restricted diet (e.g. below 3 gram per day) during the first 3 years of life will reduce the risk of develop CDA and IA in genetically predisposed children by the age of 7 years. Children who screened positive for HLA DQ2/X (X is neither DQ2 nor DQ8) in the GPPAD-02 (ASTR1D [ClinicalTrials.gov Identifier NCT03316261]) screening will be contacted by a study nurse.

The 2 groups in the trial

  • No interventionNo study treatment, for comparison

    The group will be followed without any intervention, with regular visits at the research clinic.

  • Gluten reduced dietTreatment being tested

    Subjects will follow a diet that does not exceed a daily intake of 3 gram gluten. The group will be followed with regular visits at the research clinic.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Gluten Reduction After Infancy and Risk of Celiac Disease
Record updated
13 April 2026